Central Sleep Apnea

Sleep: A Comprehensive Handbook

Volumn , Issue , 2005, Pages 249-262

  Javaheri, S ^a,b  

^a Sleepcare Diagnostics   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Central sleep apnea (CSA); CSA with upper airway disorders; Eucapnic Hypocapnic (Nonhypercapnic) CSA

Indexed keywords

EID: 51549085952     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0471751723.ch33     Document Type: Chapter

References (144)

1. Javaheri S. Heart failure. In: Kryger MH, Roth T, Dement WC (Eds), Principles and Practices of Sleep Medicine, 4th ed. Saunders, Philadelphia, 2005, pp 1208-1217.
2. Javaheri S. Central sleep apnea in congestive heart failure:prevalence, mechanisms, impacts and therapeutic options. Respir Crit Care Med 26(1):44-45(2005).
3. Javaheri S. Sleep-related breathing disorders in heart failure. In: Mann DL (Ed), Heart Failure, A Companion to Braunwald's Heart Disease. Saunders, Philadelphia, 2004, pp 471-487.
4. Javaheri S. Determinants of carbon dioxide tension. In:Gennari X, et al. (Eds), Acid-Base Disorders. Marcel Dekker/CRC Press, Boca Raton, FL, 2005.
5. Dempsey JA, Skatrud JB. Fundamental effects of sleep state on breathing. Curr Pulmonol 9:267-304(1988).
6. Skatrud JB, Dempsey JA. Interaction of sleep state and chemical stimuli in sustaining rhythmic ventilation. J Appl Physiol 55:813-822(1983).
7. Dempsey JA, Skatrud JB. A sleep-induced apneic threshold and its consequences. Am Rev Respir Dis 133:1163-1170(1986).
8. Nakayama H, Smith CA, Rodman JR, et al. Effect of ventilatory drive on CO2 sensitivity below eupnea during sleep. Am J Crit Care Med 165:1251-1258(2002).
9. Orem J, Kubin L. Respiratory physiology: central neural control. In: Kryger MH, Roth T, Dement WC (Eds), Principles and Practices of Sleep Medicine, 3rd ed. Saunders, Philadelphia, 2000, pp 205-228.
10. American Heart Association. Heart and Stroke Statistical Update-2004. American Heart Association, Dallas, 2003.
11. Ward M. Periodic respiration. A short historical note. Ann R Coll Surg Engl 52:330-334(1973).
12. Allen E, Turk JL, Murley R. The Case Books of John Hunter FRS, Parthenon Publishing Group, New York, 1993, pp 29-30.
13. Cheyne J. A case of apoplexy, in which the fleshy part of the heart was converted into fat. Dublin Hosp Rep Commun 2:216-223(1818).
14. Stokes W. Observations on some cases of permanently slow pulse. Dublin Q J Med Sci 2:73-85(1846).
15. Javaheri S, Parker TJ,Wexler L, et al. Occult sleep-disordered breathing in stable congestive heart failure. Ann Intern Med 122:487-492(1995). [Erratum, Ann Intern Med 123:77(1995).]
16. Hanly PJ, Millar TW, Steljes DG, et al. Respiration and abnormal sleep in patients with congestive heart failure. Chest 96:480-488(1989).
17. Javaheri S, Parker TJ, Liming JD, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure: types and their prevalences, consequences, and presentations. Circulation 97:2154-2159(1998).
18. Javaheri S. Sleep disorders in 100 male patients with systolic heart failure. A prospective study. Int J Cardiol (in press).
19. Tremel F, Pépin J-L, Veale D, et al. High prevalence and persistence of sleep apnea in patients referred for acute left ventricular failure and medically treated over 2 months. Eur Heart J 20:1201-1209(1999).
20. Solin P, Bergin P, Richardson M, et al. Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 99:1574-1579(1999).
21. Sin DD, Fitzgerald F, Parker JD, et al. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 160:1101-1106(1999).
22. Yasuma F, Nomura H, Hayashi H, et al. Breathing abnormalities during sleep in patients with chronic heart failure. Jpn Circ J 53:1506-1510(1989).
23. Lofaso F, Verschueren P, Rande JLD, et al. Prevalence of sleep-disordered breathing in patients on a heart transplant waiting list. Chest 106:1689-1694(1994).
24. Fries R, Bauer D, Heisel A, et al. Clinical significance of sleep-related breathing disorders in patients with implantable cardioverter defibrillators. Pace 22:223-227(1999).
25. Staniforth AD, Kinnear WJM, Starling R, et al. Nocturnal desaturation in patients with stable heart failure. Heart 79:394-399(1998).
26. Lanfranchi PA, Braghiroli A, Bosimini E, et al. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 99:1435-1440(1999).
27. Xie A, Skatrud JB, Puleo DS, et al. Apnea-hypopnea threshold for CO2 in patients with congestive heart failure. Am J Respir Crit Care Med 165:1245-1250(2002).
28. Tkacova R, Hall ML, Luie PP, et al. Left ventricular volume in patients with heart failure and Cheyne-Stokes respiration during sleep. Am J Respir Crit Care Med 156:1549-1555(1997).
29. Hanly P, Zuberi N, Gray R. Pathogenesis of Cheyne-Stokes respiration in patients with congestive heart failure. Relationship to arterial PCO2. Chest 104:1079-1084(1993).
30. Naughton M, Bernard D, Tam A, et al. Role of hyperventilation in the pathogenesis of central sleep apneas in patients with congestive heart failure. Am Rev Respir Dis 148:330-338(1993).
31. Javaheri S, Corbett WS. Association of low PaCO2 with central sleep apnea and ventricular arrhythmias in ambulatory patients with stable heart failure. Ann Intern Med 128:204-207(1998).
32. Javaheri S. Central sleep apnea and heart failure. Letter to the Editor. Circulation 342:293-294(2000).
33. Zhou XS, Shahabuddin S, Zahn BR, et al. Effect of gender on the development of hypocapnic apnea/hypopnea during NREM sleep. J Appl Physiol 89:192-199(2000).
34. Zhou XS, Rowley JA, Demirovic F, Diamond MP, Badr MS. Effect of testosterone on the apnea threshold in women during NREM sleep. J Appl Physiol 94:101-107(2003).
35. Javaheri S. A mechanism of central sleep apnea in patients with heart failure. N Engl J Med 341:949-954(1999).
36. Cherniack NS. Respiratory dysrhythmias during sleep. N Engl J Med 305:325-330(1981).
37. Khoo MCK, Kronauer RE, Strohl KP, et al. Factors inducing periodic breathing in humans: a general model. J Appl Physiol 53:644-659(1982).
38. Cherniack NS, Longobardo GS. Cheyne-Stokes breathing:an instability in physiologic control. N Engl J Med 288:952-957(1973).
39. Carley DW, Shannon DC. A minimal mathematical model of human periodic breathing. J Appl Physiol 65:1400-1409(1988).
40. Cherniack NS. Apnea and periodic breathing during sleep. N Engl J Med Sep 23;341(13):985-987(1999).
41. Khoo MCK. Theoretical models of periodic breathing in sleep apnea. In: Bradley TD, Floras JS (Eds), Implications in Cardiovascular and Cerebrovascular Disease. Marcel Dekker, New York, 2000, pp 146, 335-384.
42. Guyton AC, Crowell JW, Moore JW. Basic oscillating mechanisms of Cheyne-Stokes breathing. Am J Physiol 187:395-398(1956).
43. Younes M. The physiologic basis of central apnea and periodic breathing. Curr Pulmonol 10:265-326(1989).
44. Millar TW, Hanly PJ, Hunt B, et al. The entrainment of low frequency breathing periodicity. Chest 98:1143-1148(1990).
45. Hall MJ, Xie A, Rutherford R, et al. Cycle length of periodic breathing in patients with and without heart failure. Am J Respir Crit Care Med 154:376-381(1996).
46. Javaheri S. Treatment of central sleep apnea in heart failure. Sleep 23:S224-S227 (2000).
47. Javaheri S, Abraham WT, Brown C, Nishiyama H, Giesting R, Wagoner LE. Prevalence of obstructive sleep apnea and periodic limb movement in 45 subjects with heart transplantation. Eur Heart J 25:260-266(2004).
48. Javaheri S. Pembrey's dream: the time has come for a longterm trial of nocturnal supplemental nasal oxygen to treat central sleep apnea in congestive heart failure. Chest 123:322-325(2003).
49. Javaheri S, Parker TJ, Wexler L, et al. Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med 335:562-567(1996).
50. Javaheri S. Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation 101:392-397(2000).
51. Naughton MT, Liu PP, Benard DC, et al. Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. Am J Respir Crit Care Med 151:92-97(1995).
52. Sin DD, Logan AG, Fitzgerald FS, et al. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 102:61-66(2000).
53. Teschler H, Döhring J, Wang YM, et al. Adaptive pressure support servo-ventilation. Am J Respir Crit Care Med 164:614-619(2001).
54. Javaheri S. Heart failure and sleep apnea: emphasis on practical therapeutic options. Chest Clinics of North America. Clin Chest Med 24:207-222(2003).
55. Garrigue S, Bordier P, Jaïs P, et al. Benefit of atrial pacing in sleep apnea syndrome. N Engl J Med 346:404-412(2002).
56. Bradley TD, McNicholas WT, Rutherfored R, Popkin J, Zamel N, Phillipson EA. Clinical and physiologic heterogeneity of the central sleep apnea syndrome. Am Rev Respir Dis 134:217-221(1986).
57. Bradley TD, Phillipson EA. Central sleep apnea. Clin Chest Med 13:493-505(1992).
58. White DP, Zwillich CW, Pickett CK, Douglas NJ, Findley LJ, Weil JV. Central sleep apnea; improvement with acetazolamide therapy. Arch Intern Med 142:1816-1819(1982).
59. DeBacker WA, Verbraecken J, Willemen M, Wittesaele W, DeCock W, deHeyning PV. Central apnea index decreases after prolonged treatment with acetazolamide. Am J Respir Crit Care Med 151:87-91(1995).
60. Hommura F, Nishimura M, Oguri M, Makita H, Hosokaw K, Saito H, Miyamoto K, Kawakami Y. Continuous versus bilevel positive airway pressure in patient with idiopathic central sleep apnea. Am J Respir Crit Care Med 155:1482-1485(1997).
61. Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med 351:1655-1665(2004).
62. Schulz R, Baseler G,Ghofrani HA, Grimminger F, Olschewski H, Seeger W. Nocturnal periodic breathing in primary pulmonary hypertension. Eur Respir J 19:658-663(2002).
63. Schulz R, Fegbeutel C, Olschewski H, Rose F, Schafers HJ, Seager W. Reversal of nocturnal periodic breathing in primary pulmonary hypertension after lung transplantation. Chest 125:344-347(2004).
64. Shiomi T, Guilleminault C, Sasanabe R, Oki Y, Hasegawa R, Otake K, Banno K, Usui K, Meakawa M, Kanayama H, Takahashi R, Kobayashi T. Primary pulmonary hypertension with central sleep apnea-sudden death after bilevel positive airway pressure therapy. Jpn Circ J 64:723-726(2000).
65. Young T, Javaheri S. Systemic and pulmonary hypertension in obstructive sleep apnea. In: Kryger MH, Roth T, Dement WC (Eds), Principles and Practices of Sleep Medicine, 4th ed. Saunders, Philadelphia, 2005.
66. Weil JV. Sleep at high altitude. In: Kryger MH, Roth T, Dement WC (Eds), Principles and Practices of Sleep Medicine, 3rd ed. Saunders, Philadelphia, 2000, pp 204-253.
67. White DP, Gleeson K, Pickett CK, Rannels AM, Cymerman A, Weil JV. Altitude acclimatization: influence on periodic breathing and chemoresponsiveness during sleep. J Appl Physiol 63:401-412(1987).
68. Sutton JR, Houstion CS, Mansell AL, McFadden MD, Rigg JRA, Powles ACP. Effect of acetazolamide on hypoxemia during sleep at high altitude. N Engl J Med 301:1329-1331(1979).
69. Greene MK, Kerr AM, McIntosh IB, Prescott RJ. Acetazolamide in prevention of acute mountain sickness: a double-blind controlled cross-over study. Br Med J 283:811(1981).
70. Yaggi H, Mohsenin V. Obstructive sleep apnoea and stroke. Lancet Neurol 3:333-342(2004).
71. Hermann DM, Bassetti CL. Sleep-disordered breathing and stroke. Curr Opin Neurol 16:87-90 (2003).
72. Yaggi H, Mohsenin V. Sleep-disordered breathing and stroke. Clin Chest Med 24:223-237(2003).
73. Dyken ME, Somers VD, Yamada T, Ren Z-Y, Zimmerman MB. Investigating the relationship between stroke and obstructive sleep apnea. Stroke 27:401-407(1996).
74. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Nieto FJ, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163:19-25(2001).
75. Parra O, Arboix A, Bechich S, Garcia-Eroles L, Montserrat JM, López JA, et al. Time course of sleep-related breathin disorders in first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med 161:375-380(2000).
76. Brown HW, Plum F. The neurologic basis of Cheyne-Stokes respiration. Am J Med 30:849-860(1961).
77. Nachtmann A, Siebler M, Rose G, Sitzer M, Steinmetz H. Cheyne-Stokes respiration in ischemic stroke. Neurology 45:820-821(1995).
78. North JB, Jennett S. Abnormal breathing patterns associated with acute brain damage. Arch Neurol 31:338-344(1974).
79. Heyman A, Birchfield RI, Sieker HO. Effects of bilateral cerebral infarction on respiratory center sensitivity. Neurology 8:694-700(1958).
80. Boden AG, Harris MC, Parkes MJ. Apneic threshold for CO2 in the anesthetized rat: fundamental properties under steady-state conditions. J Appl Physiol 85:898-907(1998).
81. Mellins RB, Balfour HH, Turino GM,Winters RW. Failure of automatic control of ventilation (Ondine's curse). Medicine 49:487-504(1970).
82. Vanderlaan M, Holbrook CR, Wang M, Tuell A, Gozal D. Epidemiologic survey of 196 patients with congenital central hypoventilation syndrome. Pediatr Pulmonol 37:217-229(2004).
83. Trochet D, O'Brien LM, Gozal D, Trang H, Nordenskjöld A, Laudier B, et al. PHOX2B genotype allows for prediction of tumor risk in congenital central hypoventilation syndrome. Am J Hum Genet 76:421-426(2005).
84. Trang H, Dehan M, Beaufils F, Zaccaria I, Amiel J, Gaultier C. The French congenital central hypoventilation syndrome registry: general date, phenotype, and genotype. Chest 127:72-79(2005).
85. Blanchi B, Sieweke MH. Mutations of brainstem transcription factors and central respiratory disorders. Trends Mol Med 11:23-30(2005).
86. Amiel J, et al. Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome. Nat Genet 33:459-461(2003).
87. Sasaki A, et al. Molecular analysis of congenital central hypoventilation syndrome. Hum Genet 114:22-26(2003).
88. Weese-Mayer DE, et al. Idiopathic congenital central hypoventilation syndrome: analysis of genes pertinent to early autonomic nervous system embryologic development and identification of mutations in PHOX2B. Am J Med Genet 123:267-278(2003).
89. Dauger S, et al. PHOX2B controls the development of peripheral chemoreceptors and afferent visceral pathways. Development 130:6635-6642(2003).
90. Blanchi B, et al. MafB deficiency causes defective respiratory rhythinogenesis and fatal central sleep apnea at birth. Nat Neurosci 6:1091-1100(2003).
91. Cirignotta F, Schiavina M, Mondini S, Lugaresi A, Fabiani A, Cortelli P, Lugaresi E. Central alveolar hypoventilation (Ondine's curse) treated with negative pressure ventilation. Monaldi Arch Chest Dis 51:22-26(1996).
92. Flageole H, Adolph VR, Davis GM, Laberge JM, Nguyen LT, Guttman FM. Diaphragmatic pacing in children with congenital central alveolar hypoventilation syndrome. Surgery 118:25-28(1995).
93. Garrido-Garcia H, Alvarez JM, Escribono PM, La Banda F, Cambarrutta C, Gracia ME, Labarta C, Arroyo O, De la Cruz FS, Gutierrrez R, Moreno JG. Treatment of chronic ventilatory failure using a diaphragmatic pacemaker. Spinal Cord 36:310-314(1998).
94. Oren J, Newth CJL, Hung CE, Brouillette RT, Bachand RT, Shannon DC. Ventilatory effects of almitrine bismesylate in congenital central hypoventilation syndrome. Am Rev Respir Dis 134:917-919(1986).
95. Reichel J. Primary alveolar hypoventilation. Clin Chest Med 1:119-124(1980).
96. Bubis MJ, Anthonisen NR. Primary alveolar hypoventilation treated by nocturnal administration of O2. Am Rev Respir Dis 118:947-953(1978).
97. McNicholas WT, Carter JL, Rutherford R, Zamel N, Phillipson EA. Beneficial effect of oxygen on primary alveolar hypoventilation with central sleep apnea. Am Rev Respir Dis 125:773-775(1982).
98. Guilleminault C, Stoohs R, Schneider H, Podszus T, Peter JH, von Wichert P. Central alveolar hypoventilation and sleep: treatment by intermittent positive-pressure ventilation through nasal mask in an adult. Chest 96:1210-1212 (1989).
99. Man GCW, Jones RL, MacDonald GF, King EG. Primary alveolar hypoventilation managed by negative-pressure ventilators. Chest 76:219-221(1979).
100. Garay SM, Turino GM, Goldring RM. Sustained reversal of chronic hypercapnia in patients with alveolar hypoventilation syndromes. Am J Med 70:269-274(1981).
101. Farmer WC, Glenn WW, Gee JBL. Alveolar hypoventilation syndrome: studies of ventilatory control in patients selected for diaphragm pacing. Am J Med 64:39-49(1978).
102. Glenn WWL, Gee JBL, Cole DR, Farmer WC, Shaw RK, Beckman CB. Combined central alveolar hypoventilation and upper airway obstruction. Am J Med 64:50-60(1978).
103. Cohn JE, Kuida H. Primary alveolar hypoventilation associated with western equine encephalitis. Ann Intern Med 56:633-644(1962).
104. White DP, Miller F, Erickson RW. Sleep apnea and nocturnal hypoventilation after western equine encephalitis. Am Rev Respir Dis 127:132-133(1983).
105. Devereaux MW, Keane JR, Davis RL. Automatic respiratory failure associated with infarction of the medulla: report of two cases with pathologic study of one. Arch Neurol 29:46-52(1973).
106. Levin BE, Margolis G. Acute failure of automatic respirations secondary to a unilateral brainstem infarct. Ann Neurol 1:583-586(1977).
107. Kraus J, Heckmann JG, Druschky A, Erbguth F, Neundörfer B. Ondine's curse in association with diabetes insipidus following transient vertebrobasilar ischemia. Clin Neurol Neurosurg 101:196-198(1999).
108. Manning HL, Leiter JC. Respiratory control and respiratory sensation in a patient with a ganglioglioma within the dorsocaudal brain stem. Am J Respir Crit Care Med 161:2100-2106(2000).
109. Cummiskey J, Guilleminault C, Davis R, Duncan K, Golden J. Automatic respiratory failure: sleep studies and Leigh's disease. Neurology 37:1876-1878(1987).
110. Schulz R, Fegbeutel C, Althoff A, Traupe H, Grimminger F, Seeger W. Central sleep apnoea and unilateral diaphragmatic paralysis associated with vertebral artery compression of the medulla oblongata. J Neurol 250:503-505(2003).
111. Yglesias A, Narbona J, Vanaclocha V, Artieda J. Chiari type 1 malformation, glossopharyngeal neuralgia and central sleep apnea in a child. Child Neurol 38:1126-1130(1996).
112. Severinghaus JW, Mitchell RA. Onidine's curse: failure of respiratory center automacity while awake. Clin Res 10:122(1962).
113. Manconi M, Mondini S, Fabiani A, Rossi P, Ambrosetto P, Cirignotta F. Anterior spinal artery syndrome complicated by the Ondine curse. Arch Neurol 60:1787-1790(2003).
114. George CFP. Neuromuscular disorders. In: Kryger MH, Roth T, Dement WC (Eds), Principles and Practices of Sleep Medicine, 3rd ed. Saunders, Philadelphia, 2000, pp 1087-1092.
115. Kerby GR, Mayer LS, Pingleton SK. Nocturnal positive pressure ventilation via nasal mask. Am Rev Respir Dis 135:738-740(1987).
116. Ellis ER, Bye PTP, Bruderer JW, Sullivan CE. Treatment of respiratory failure during sleep in patients with neuromuscular disease: positive-pressure ventilation through a nose mask. Am Rev Respir Dis 135:148-152(1987).
117. Newson-Davis IC, Lyall RA, Leigh PN, Moxham J, Goldstein LH. The effect of non-invasive positive pressure ventilation (NIPPV) on cognitive function in amyotrophic lateral sclerosis: a prospective study. J Neurol Psychiatry 71:482-487(2001).
118. Goldstein RS, Molotiu N, Skrastins R, Long S, De Rosie J, Contreras M, Popkin J, Rutherford R, Phillipson EA. Reversal of sleep-induced hypoventilation and chronic respiratory failure by nocturnal negative pressure ventilation in patients with restrictive ventilatory impairment. Am Rev Respir Dis 135:1049-1055(1987).
119. Santiago TV, Edelman NH. Opioids and breathing. J Appl Physiol 59:1675-1685(1985).
120. Weil JV, McCullough RE, Kline JS, Sodal IE. Diminished ventilatory response to hypoxia and hypercapnia after morphine in normal man. N Engl J Med 292:1103-1106(1975).
121. Robinson RW, Zwillich CW, Bixler EO, Cadieux RJ, Kales A, White DP. Effects of oral narcotics on sleep-disordered breathing in healthy adults. Chest 91:197-203(1987).
122. Teichtahl H, Prodromidis A, Miller B, Cherry G, Kronborg I. Sleep-disordered breathing in stable methadone programme patients: a pilot study. Addiction 96:395-403(2001).
123. Fareny RJ, Walker JM, Cloward TV, Rhondeau S. Sleepdisordered breathing associated with long-term opioid therapy. Chest 123:632-639(2003).
124. Grunstein RR, Ho KKY, Sullivan CE. Sleep apnea in acromegaly. Ann Intern Med 115:527-532(1991).
125. Colas A, Fergone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25:102-152(2004).
126. Rosenow F, McCarthy V, Caruso AC. Sleep apnea in endocrine diseases. J Sleep Res 7:3-11(1998).
127. Grunstein RR, Ho KKY, Sullivan CE. Effect of octreotide, a somatostatin analog, on sleep apnea in acromegaly. Ann Intern Med 121:478-487(1994).
128. Herrmann BL, Wessendorf TE, Ajaj W, Kahlke S, Teschler H, Mann K. Effects of octreotide on sleep apnea and tongue volume (magnetic resonance imaging) in patients with acromegaly. Eur J Endocrinol 151:309-315(2004).
129. Grunstein RR, Ho KKY, Berthon-Jones M, Stewart D, Sullivan CE. Central sleep apnea is associated with increased ventilatory response to carbon dioxide and hypersecretion of growth hormone in patients with acromegaly. Am J Respir Crit Care Med 150:496-502(1994).
130. Rajagopal KR, Abbrecht PH, Derderian SS, Pickett C, Hofeldt F, Tellis CJ, Zwillich CW. Obstructive sleep apnea in hypothyroidism. Ann Intern Med. 101:491-494(1984).
131. Meyrier A. Central sleep apnea in hypothyroidism. Am Rev Respir Dis 127:504-507(1983).
132. Fletcher EC. Recurrence of sleep apnea syndrome following tracheostomy. A shift from obstructive to central sleep apnea. Chest 96:205-209(1969).
133. Widdicombe J. Airway receptors. Respir Physiol 125:3-15(2001).
134. James JEA, Daly MB. Nasal reflexes. Proc R Soc Med 62:1287-1293(1969).
135. Storey AT, Johnson P. Laryngeal receptors initiating apnea in lamb. Exp Neurol 47:42-55(1975).
136. Harms CA, Zeng Y-J, Smith CA, Vidruk EH, Dempsey JA. Negative pressure-induced deformation of the upper airway causes central apnea in awake and sleeping dogs. J Appl Physiol 80:1528-1539(1996).
137. Lawson EE. Prolonged central respiratory inhibition following reflex-induced apnea. J Appl Physiol: Respirat Environ Exercise Physiol 50:874-879(1981).
138. Davis AM, Koenig JC, Thack BT. Upper airway chemoreflex responses to saline and water in preterm infants. J Appl Physiol 64:1412-1420(1988).
139. Suratt PM, Turner BL, Wilhoit SC. Effect of intranasal obstruction on breathing during sleep. Chest 90:324-329(1986).
140. Zwillich CW, Pickett C, Hanson FN, Weil JV Jr. Disturbed sleep and prolonged apnea during nasal obstruction in normal man. Am Rev Respir Dis 124:158-160(1981).
141. McNicholas WT, Tavlo S, Cole P, Zamel N, Rutherford R, Griffin D, Phillipson EA. Obstructive apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis 126:625-628(1982).
142. Henke KG, Sullivan CE. Effects of high-frequency pressure waves applied to upper airway on respiration in central apnea. J Appl Physiol 73:1141-1145(1992).
143. Issa FG, Sullivan CE. Reversal of central sleep apnea using nasal CPAP. Chest 90:165-171(1986).
144. Hoffstein V, Slutsky AS. Central sleep apnea reversed by continuous positive airway pressure. Am Rev Respir Dis 135:1210-1212(1987).